RPID (Rapid Micro Biosystems) Buyback Yield %: 0.00 (As of Jul. 07, 2026)


RPID Rapid Micro Biosystems Inc RPID
60 GF Score
Price $1.78
GF Value $1.89
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Rapid Micro Biosystems Buyback Yield %?

Rapid Micro Biosystems RPID +0.85% 60 Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus rates RPID with a GF Score™ of 60/100 and a GF Value™ of $1.89 (Fairly Valued). The stock has 4 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Rapid Micro Biosystems ranks worse than 288184.15% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Rapid Micro Biosystems's current buyback yield was 0.00%.


Rapid Micro Biosystems Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Rapid Micro Biosystems's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Micro Biosystems Buyback Yield % Chart

Rapid Micro Biosystems Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial -37.20 0.00 0.00 0.00 -0.35

Rapid Micro Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.35 0.00

RPID vs OM, NNOX, STIM: Buyback Yield % Comparison

For the Medical Devices subindustry, Rapid Micro Biosystems's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Micro Biosystems Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Rapid Micro Biosystems's Buyback Yield % falls into.


RPID
60GF Score
Rapid Micro Biosystems Inc RPID
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rapid Micro Biosystems Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Rapid Micro Biosystems's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.445) / 128.963
=-0.35%

Rapid Micro Biosystems's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 103.89109
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Rapid Micro Biosystems (RPID) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rapid Micro Biosystems and its competitors. According to the industry distribution chart, Rapid Micro Biosystems ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Rapid Micro Biosystems' Buyback Yield % too high?
Rapid Micro Biosystems' current Buyback Yield % is 0.00. Based on the distribution chart, Rapid Micro Biosystems ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rapid Micro Biosystems has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rapid Micro Biosystems' Buyback Yield % compare to OM and NNOX?
According to the Medical Devices & Instruments industry distribution chart, Rapid Micro Biosystems ranks #999999 out of 347 companies for Buyback Yield %. This places Rapid Micro Biosystems in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rapid Micro Biosystems and its competitors. Rapid Micro Biosystems's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Micro Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Rapid Micro Biosystems (RPID) is currently considered Fairly Valued. The stock's GF Value™ is $1.89, compared to a current price of $1.78 — trading 5.8% below its estimated fair value. The current Buyback Yield % is 0.00. Rapid Micro Biosystems' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Rapid Micro Biosystems (RPID), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Micro Biosystems (RPID) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be undervalued. The current stock price of $1.78 is trading 5.8% below its estimated GF Value™ of $1.89. GuruFocus considers Rapid Micro Biosystems to be Fairly Valued.

Key valuation signals for RPID:

  • Buyback Yield %: 0.00
  • GF Value™: $1.89 vs. price of $1.78 (5.8% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rapid Micro Biosystems Business Description

Address 25 Hartwell Avenue, Lexington, MA, USA, 02421
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
60GF Score

Get the complete analysis for RPID

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.78
Price
$1.89
GF Value